Marimed (MRMD) Shares Outstanding (Weighted Average) (2011 - 2026)

Marimed (MRMD) has 16 years of Shares Outstanding (Weighted Average) data on file, last reported at $397.4 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $397.4 million, up 3.89% year-over-year; the trailing twelve-month figure through Mar 2026 was $397.4 million (up 3.89% YoY), and the FY2025 annual result was $390.1 million, up 2.9% from the prior year.
• Shares Outstanding (Weighted Average) grew to $397.4 million in Q1 2026 per MRMD's latest filing, from $390.1 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $397.4 million in Q1 2026 and troughed at $334.8 million in Q1 2022.
• A 5-year average of $366.3 million and a median of $375.2 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Weighted Average) gained 9.68% in 2022, then climbed 1.96% in 2025.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $337.7 million in 2022, then gained by 7.61% to $363.4 million in 2023, then advanced by 4.33% to $379.2 million in 2024, then gained by 2.9% to $390.1 million in 2025, then advanced by 1.87% to $397.4 million in 2026.
• Business Quant data shows MRMD's Shares Outstanding (Weighted Average) at $397.4 million in Q1 2026, $390.1 million in Q4 2025, and $392.6 million in Q3 2025.